AUTL PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d

AUTL ▲ +1.88% at T+20d

NEUTRAL call ✓ call won +1.88% · α vs SPY -1.29% · entry $1.60 → $1.63

Next anchor: T+60d in 4w

Last close $1.56 (close Jun 12) · -2.50% from $1.60 entry

Entry anchored
Apr 21, 03:59 PM ET
via Databento tick

T+1d

-4.38%

call -4.38% · α -3.98%

$1.53

settled 8w ago

T+5d

-11.56%

call -11.56% · α -11.62%

$1.42

settled 7w ago

T+20d

+1.88%

call +1.88% · α -1.29%

$1.63

settled 27d ago

T+60d

—

call — · α —

—

in 4w

Price Chart

Loading chart...

Executive Summary

Autolus Therapeutics granted stock options for 68,500 ADSs and 57,765 RSUs to 15 new employees as inducement awards under its 2025 Inducement Plan. The awards, priced at $1.47 per share, vest over four years and are intended to attract talent, but represent a minor dilutive impact.

Actionable Insight

Monitor future 10-Q filings for incremental share count changes and stock-based compensation expenses. This is a routine hiring incentive and not a material event; no immediate trading implication.

Key Facts

Granted stock options for 68,500 ADSs and 57,765 RSUs to 15 new employees
Awards made under Nasdaq Listing Rule 5635(c)(4) as inducement grants
Exercise price of $1.47 equals closing price on April 13, 2026
Options vest over four years (25% at year one, then monthly); RSUs vest in four equal annual installments
No financial performance metrics or material business developments disclosed

Financial Impact

Approximately 126,265 shares subject to awards, representing ~0.3% of Autolus' current market cap ($421M) if fully diluted at $1.47/share

dilutionshare_countcompensation_expense

Risk Factors

Potential for modest dilution upon exercise of options and vesting of RSUs
Inducement grants may signal aggressive hiring in a cash-intensive phase, increasing burn rate

Market Snapshot

Exchange

Nasdaq

Sector

Biological Products, (No Diagnostic Substances)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3278431

9 reports for AUTL

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for AUTL — sortable, filterable
	Type				Now
Jun 12, 2026 3d ago	Press Release NEUTRAL ★ 3/10	$1.57 awaiting T+5	awaiting T+5	—	$1.56 (−0.64%)
Jun 11, 2026 3d ago	Institutional Cluster BEARISH ★ 6/10	$1.56 awaiting T+5	awaiting T+5	—	$1.56 (−0.32%)
Jun 9, 2026 5d ago	8-K BEARISH ★ 7/10	$1.45 awaiting T+5	awaiting T+5	—	$1.56 (−7.59%)
May 21, 2026 24d ago	Press Release NEUTRAL ★ 4/10	$1.70 $1.84	▲ +8.24%	▲ +6.58%	$1.56 (−8.24%)
May 14, 2026 4w ago	8-K MIXED ★ 6/10	$1.59 $1.65	▲ +3.77%	▲ +4.49%	$1.56 (−1.89%)
May 14, 2026 4w ago	Press Release MIXED ★ 6/10	$1.59 $1.65	▲ +3.77%	▲ +4.49%	$1.56 (−1.89%)
Apr 21, 2026 7w ago	Press Release NEUTRAL ★ 3/10	$1.60 $1.42	▼ −11.56%	▼ −11.62%	$1.56 (−2.50%)
Apr 8, 2026 9w ago	8-K BULLISH ★ 6/10	$1.47 $1.61	▲ +9.52%	▲ +6.34%	$1.56 (+6.12%)
Mar 16, 2026 12w ago	Press Release NEUTRAL ★ 3/10	$1.51 $1.32	▼ −12.58%	▼ −9.93%	$1.56 (+3.31%)

US Market Status

Market Closed — Opens in 5h 4m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access